Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-03-31): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
0.00%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
OKYO Pharma Limited
Market Cap
$56.98M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$57.54M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$58.47M
Operating Margin
0.00%
TTM Avg
-50285.49%
3Y Avg
-35733.57%
5Y Avg
-23822.38%
Market Cap
$59.66M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.28M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$53.62M
Operating Margin
-43.78%
TTM Avg
-33.02%
3Y Avg
-37.09%
5Y Avg
-29.30%
Market Cap
$60.08M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$53.63M
Operating Margin
-6056.37%
TTM Avg
-3556.76%
3Y Avg
-2097.71%
5Y Avg
-1497.54%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OKYO Pharma Limited (OKYO) | $56.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Boundless Bio, Inc. (BOLD)vs › | $57.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fractyl Health, Inc. (GUTS)vs › | $58.47M | 0.00% | -50285.49% | -35733.57% | -23822.38% |
| Aldeyra The (ALDX)vs › | $53.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| PDS Biotechnology Corporation (PDSB)vs › | $59.28M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | -43.78% | -33.02% | -37.09% | -29.30% |
| MiNK Therapeutics, Inc. (INKT)vs › | $60.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $53.63M | -6056.37% | -3556.76% | -2097.71% | -1497.54% |
| Adicet Bio, Inc. (ACET)vs › | $60.86M | 0.00% | 0.00% | -72.58% | -190.10% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-10-01 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-03-31 | 0.00% |
